NYSE · Healthcare
ARTIVION, INC. (AORT)
As-reported financials and recent SEC filings for ARTIVION, INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$441.3M
Net income
$9.8M
Net margin
2.2%
Diluted EPS
$0.21
ROE
2.2%
P/E (TTM)
94.4×
Market cap
$1.15B
Debt / equity
0.5×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $441.3M | $388.5M | $354.0M | $313.8M | $298.8M |
| Gross profit | $284.2M | $248.8M | $229.2M | $202.5M | $197.5M |
| Operating income | $33.7M | $38.9M | $5.7M | $6.2M | $8.1M |
| Net income | $9.8M | $-13.4M | $-30.7M | $-19.2M | $-14.8M |
| Diluted EPS | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-15
View on EDGAR →1442026-06-11
View on EDGAR →32026-06-08
View on EDGAR →42026-06-04
View on EDGAR →SD2026-05-21
View on EDGAR →4/A2026-05-20
View on EDGAR →42026-05-20
View on EDGAR →42026-05-20
View on EDGAR →Go deeper on AORT
Search ARTIVION, INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.